SARS-CoV-2 genomic diversity and within-host evolution in individuals with persistent infection in the UK: an observational, longitudinal, population-based surveillance study
GHAFARI M. et al, (2025), The Lancet Microbe
Second-Line antiretroviral therapy for children iving with HIV in Africa
Musiime V. et al, (2025), New England Journal of Medicine
Transformers and large language models are efficient feature extractors for electronic health record studies.
Yuan K. et al, (2025), Commun Med (Lond), 5
Identification of undetected SARS-CoV-2 infections by clustering of Nucleocapsid antibody trajectories
Zwerwer LR. et al, (2025), Nature Communications
Survey of healthcare-associated sink infrastructure, and sink trap antibiotic residues and biochemistry, in 29 UK hospitals
RODGER G. et al, (2025), Journal of Hospital Infection
Treatment options to support the elimination of Hepatitis C: an open label, factorial randomised controlled trial
Cooke G. et al, (2025), The Lancet
Safety reporting in neonatal clinical trials: reflections towards optimal, globally relevant approaches
Hill L. et al, (2025), Trials
Machine learning and clinician predictions of antibiotic resistance in Enterobacterales bloodstream infections.
Yuan K. et al, (2024), J Infect
Addition of macrolide antibiotics for hospital treatment of community-acquired pneumonia
Wei J. et al, (2024), Journal of Infectious Diseases
Developing a Framework for Tracking Antimicrobial Resistance Gene Movement in a Persistent Environmental Reservoir
Mathers A. et al, (2024), npj Antimicrobials and Resistance
Real-time modelling of the SARS-CoV-2 pandemic in England 2020-2023: a challenging data integration
Birrell PJ. et al, (2024), Journal of the Royal Statistical Society: Series A (Statistics in Society)
Predicting individual patient and hospital-level discharge using machine learning
Wei J. et al, (2024), Communications Medicine
Azithromycin in severe malaria bacterial co-infection in African children (TABS-PKPD): a Phase II randomised controlled trial
Connon R. et al, (2024), BMC Medicine
Determining Targets for Antiretroviral Drug Concentrations: a Causal Framework Illustrated with Pediatric Efavirenz Data from the CHAPAS-3 Trial
Schomaker M. et al, (2024), Pharmacoepidemiology and Drug Safety
Identification of undetected SARS-CoV-2 infections by clustering of Nucleocapsid antibody trajectories
Zwerwer LR. et al, (2024)
How, why and when are delayed (back-up) antibiotic prescriptions used in primary care? A realist review integrating concepts of uncertainty in healthcare
Mcleod M. et al, (2024), BMC Public Health, 24
Global burden of bacterial antimicrobial resistance 1990-2021: a systematic analysis with forecasts to 2050.
GBD 2021 Antimicrobial Resistance Collaborators None., (2024), Lancet, 404, 1199 - 1226